price close busi juli
develop manufactur market devic
instrument orthoped
biomed devic servic
bottom line maintain buy rate follow result came
ahead cg/street expect sale y/i
organ came slightli ahead cg/street estim
strength driven momentum across entir portfolio especi
knees/mako instrument neurotech oper adj ep beat
cg/consensu adj om y/i came
estim better expect oper leverag continu benefit
strong top line sale execut compani ctg cost save initi
despit dilut invest om headwind effort like
erp mako
net-net result reinforc thesi continu deliv msd
organ revenu growth continu take market share across board
begin benefit meaning halo effect mako placement someth
expect continue/acceler note underli new product cycl
medsurg ortho/recon support fundament momentum across
market someth feel lost major mako-focus investor
sum expens ep expect best class execut
new product cycl drive upsid bia estim throughout buy
revenu detail chang exclud impact report
sale growth organ support us sale growth
sale growth xfx orthoped grew strong
perform us knee ou knee xfx us trauma/extrem
medsurg continu solid growth driven strength endoscopi
medic respect neurotech spine also
strong post growth driven demand neurotech intervent spine
product off-set soft global core spine busi
guidanc increas organ revenu guidanc
 someth think posit upsid given on-going
momentum across us ortho medsurg neurotech heel new product
launch mako adopt
mako place mako system ww y/i inclus system
place us upgrad system
q/q manag reiter expect major
robot upgrad procedur total
repres mako procedur ytd place system
competit account q/q still line histor norm
reinforc thesi competit share gain across entir product portfolio
manag reiter total knee sale continu grow faster account
mako tka system compar without lastli note
place mako ortho hospit demonstr earli natur
opportun potenti continu momentum opportun
becom confid follow recent dilig robot link
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
factset compani report canaccord genuiti estim
given better expect result ytd increas full-year organ
revenu growth guidanc rang
previous accordingli adjust ep guidanc increas rang
 previous adjust ep expect
rang guidanc includ impact busi invest
mako erp system entl acquisit manag
note updat guidanc includ reduct fx favor
chang estim
made follow chang estim
biomed devic servic
performanceactualcg estbeat/missconsensusbeat/missnet good gross gross special oper ex chg pro-forma oper net ep ex one-tim chg result categoryactualcg net sale
figur chang estim
large-cap medic devic comp group trade mean price-to-earnings multipl
given consist execut strong growth profil high end
peer group think stock justifi premium comp group sum
maintain price target price target util multipl appli
pro-forma ep estim
figur matrix discount rate impli share price target
stryker
one world lead medic technolog compani
broadly-bas rang product orthoped signific presenc
medic specialti compani product includ implant use joint
replac trauma spinal surgeri surgic equip surgic
navig system endoscop commun system patient handl
emerg medic equip medic devic product use varieti
biomed devic servic
except ep newold newold newold revenu operatin net pe multipl price metric use price-to-earnings valuat analysisbroad large-cap medic devic price-to-earnings multipl forma figur stryker incom statement
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
biomed devic servic
stryker corpor quarterli incom statementcanaccord genuiti kyle except per share good technolog special oper ex chg oper ex chg erest incom incom incom ex one-tim chg incom ex one-tim ep ex one-tim chg ep ex acq relat gross oper ex chg oper ex chg ex net charg net ex one-tim growth oper net incom charg ep charg ep ex acq growth net incom charg ep charg ep ex acq
biomed devic servic
stryker corpor revenu mixcanaccord genuiti kyle mix us y/i y/i xfx/x q/q q/q mixdomest stryker
